Oncoinvent Appoints Zuzana Jiráková Trnková Chief Medical Officer
Oncoinvent says Trnková will lead Phase 3 preparations for Radspherin. She brings more than 20 years of clinical development experience.
Related stories
360 Security Tech Q3 Net Profit Falls 32.1% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:46 AM UTC
Jordan Commercial Bank Reports Q3 Profit of 3.9 Million Dinars
M impact | EQUITY | Oct 29, 2026, 09:42 AM UTC
Heimar to Publish Q3 2026 Results
Heimar says it will publish its Q3 2026 results.
M impact | EQUITY | Oct 29, 2026, 09:42 AM UTC
ESAF Small Finance Bank Rises After Quarterly Profit Report
Shares of India's ESAF Small Finance Bank rose after the bank reported quarterly profit.
M impact | EQUITY | Oct 29, 2026, 09:41 AM UTC
Premier Business and Projects reports Q3 loss of 60,198 dinars
M impact | EQUITY | Oct 29, 2026, 09:41 AM UTC
May & Baker Nigeria Reports Quarterly Revenue of 11.69 Billion Naira, PBT of 4.07 Billion Naira
M impact | EQUITY | Oct 29, 2026, 09:40 AM UTC